✦ LIBER ✦

Serial plasma carcinoembyonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy

Book ID: 122911782
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 200 KB
Volume: 2
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(86)80742-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serial plasma carcinoembyonic antigen (C

Serial plasma carcinoembyonic antigen (CEA) measurements for monitoring patients with advanced lung cancer during chemotherapy

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Serial plasma carcinoembryonic antigen m

Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy

✍ Tetsu Shinkai; Nagahiro Saijo; Keigo Tominaga; Kenji Eguchi; Eiji Shimizu; Yasut 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

Can plasma DNA monitoring be employed in

Can plasma DNA monitoring be employed in personalized chemotherapy for patients with advanced lung cancer?

✍ Shiyang Pan; Wenying Xia; Qingqing Ding; Yongqian Shu; Ting Xu; Yan Geng; Yachun 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 821 KB

Efficacy of plasma vascular endothelial

Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer

✍ Sachin Kumar; Randeep Guleria; Vikas Singh; Alok C Bharti; Anant Mohan; Bhudev C 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 695 KB

Decline in serum carcinoembryonic antige

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer

✍ Andrea Ardizzoni; Mara A. Cafferata; Marcello Tiseo; Rosangela Filiberti; Paola 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

## Abstract ## BACKGROUND. The authors assessed the predictive and prognostic role of decline in the serum levels of carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA 21‐1) during chemotherapy in patients with advanced nonsmall cell lung cancer (NSCLC). ## METHODS. Changes in ser

Dosimetric Variations to Organs at Risk

Dosimetric Variations to Organs at Risk Based on Serial 4DCT Scans During Radiation Therapy Treatment for Patients With Locally-Advanced Non-Small Cell Lung Cancer

✍ Yap, M.; Sun, A.; Higgins, J.; Marshall, A.; Le, L.; Clarke, K.; Becker, N.; Bez 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB